
Decades of research and collaborations have transformed the outlook for cancers affecting children (ages 0 to 14) and adolescents (ages 15 to 19), collectively referred to as the pediatric cancers in this report.
Enormous progress has been made in the treatment of pediatric cancers over the past several decades, as reflected in the greater than 85 percent 5-year relative survival rates for all cancers combined.
Learn MoreResearch-driven advances in pediatric cancer science and medicine are transforming prevention, screening, and treatment options to benefit patients, survivors, and their loved ones.
Learn MoreChanges in the genome, epigenome, developmental pathways, and tumor microenvironment contribute to how pediatric cancers originate, progress, and respond to treatment.
Learn More



